Evommune, Inc 10-K for FY2025
Evommune, Inc. (EVMN)
10-K
2026-03-05
For: 2025-12-31
View Original
Added on
April 08, 2026
About this 10-K
Evommune, Inc filed this 10-K on March 5, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $13M
- up 85.7% from $7M a year earlier
- Net loss
- $68.87M
- compared with a net loss of $66.81M a year earlier
- Diluted EPS
- -$11.22
- compared with -$45.29 a year earlier